(NVKP-16-1-2016-0017 National Heart Program) Támogató: NKFIH
(2020-4.1.1.-TKP2020)
(ÚNKP-22-3-II-SE-51)
Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése(EFOP-3.6.3-VEKOP-16-2017-00009)
Támogató: EFOP-VEKOP
(ÚNKP-22-4-II-SE)
Szakterületek:
Radiológia, sugárgyógyászat és orvosi képalkotás
We aimed to evaluate whether invasive fractional flow reserve (FFRi) of non-infarction
related (non-IRA) lesions changes over time in ST-elevation myocardial infarction
(STEMI) patients. Moreover, we assessed the diagnostic performance of coronary CT
angiography-derived FFR(FFRCT) following the index event in predicting follow-up FFRi.We
prospectively enrolled 38 STEMI patients (mean age 61.6 ± 9 years, 23.1% female)
who underwent non-IRA baseline and follow-up FFRi measurements and a baseline FFRCT
(within ≤10 days after STEMI). Follow-up FFRi was performed at 45-60 days (FFRi and
FFRCT value of ≤0.8 was considered positive).FFRi values showed significant difference
between baseline and follow-up (median and interquartile range (IQR) 0.85 [0.78-0.92]
vs. 0.81 [0.73-0.90] p = 0.04, respectively). Median FFRCT was 0.81 [0.68-0.93].
In total, 20 lesions were positive on FFRCT. A stronger correlation and smaller bias
were found between FFRCT and follow-up FFRi (ρ = 0.86,p < 0.001,bias:0.01) as
compared with baseline FFRi (ρ = 0.68, p < 0.001,bias:0.04). Comparing follow-up
FFRi and FFRCT, no false negatives but two false positive cases were found. The overall
accuracy was 94.7%, with sensitivity and specificity of 100.0% and 90.0% for identifying
lesions ≤0.8 on FFRi. Accuracy, sensitivity, and specificity were 81.5%, 93.3%, and
73.9%, respectively, for identifying significant lesions on baseline FFRi using index
FFRCT.FFRCT in STEMI patients close to the index event could identify hemodynamically
relevant non-IRA lesions with higher accuracy than FFRi measured at the index PCI,
using follow-up FFRi as the reference standard. Early FFRCT in STEMI patients might
represent a new application for cardiac CT to improve the identification of patients
who benefit most from staged non-IRA revascularization.